Cite

HARVARD Citation

    Wu, X. et al. (2021). MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance. European journal of haematology. pp. 458-465. [Online]. 
  
Back to record